Skip to main content
Erschienen in: International Journal of Clinical Oncology 6/2015

01.12.2015 | Original Article

Clinical characteristics and outcome of pneumothorax after stereotactic body radiotherapy for lung tumors

verfasst von: Kaori Asai, Katsumasa Nakamura, Yoshiyuki Shioyama, Tomonari Sasaki, Yoshio Matsuo, Saiji Ohga, Tadamasa Yoshitake, Kotaro Terashima, Makoto Shinoto, Keiji Matsumoto, Hidenari Hirata, Hiroshi Honda

Erschienen in: International Journal of Clinical Oncology | Ausgabe 6/2015

Einloggen, um Zugang zu erhalten

Abstract

Backgound

We retrospectively investigated the clinical characteristics and outcome of pneumothorax after stereotactic body radiotherapy (SBRT) for lung tumors.

Methods

Between April 2003 and July 2012, 473 patients with lung tumors were treated with SBRT. We identified 12 patients (2.5 %) with pneumothorax caused by SBRT, and evaluated the clinical features of pneumothorax.

Results

All of the tumors were primary lung cancers. The severity of radiation pneumonitis was grade 1 in 10 patients and grade 2 in two patients. Nine patients had emphysema. The planning target volume and pleura overlapped in 11 patients, and the tumors were attached to the pleura in 7 patients. Rib fractures were observed in three patients before or at the same time as the diagnosis of pneumothorax. The median time to onset of pneumothorax after SBRT was 18.5 months (4–84 months). The severity of pneumothorax was grade 1 in 11 patients and grade 3 in one patient.

Conclusion

Although pneumothorax was a relatively rare late adverse effect after SBRT, some patients demonstrated pneumothorax after SBRT for peripheral lung tumors. Although most pneumothorax was generally tolerable and self-limiting, careful follow-up is needed.
Literatur
1.
Zurück zum Zitat Baumann P, Nyman J, Hoyer M et al (2009) Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 27:3290–3296CrossRefPubMed Baumann P, Nyman J, Hoyer M et al (2009) Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 27:3290–3296CrossRefPubMed
2.
Zurück zum Zitat Yoshitake T, Nakamura K, Shioyama Y et al. (2014) Stereotactic body radiation therapy for primary lung cancers clinically diagnosed without pathological confirmation: a single-institution experience. Int J Clin Oncol (in press) Yoshitake T, Nakamura K, Shioyama Y et al. (2014) Stereotactic body radiation therapy for primary lung cancers clinically diagnosed without pathological confirmation: a single-institution experience. Int J Clin Oncol (in press)
3.
Zurück zum Zitat Siva S, MacManus M, Ball D (2010) Stereotactic radiotherapy for pulmonary oligometastases: a systematic review. J Thorac Oncol 5:1091–1099PubMed Siva S, MacManus M, Ball D (2010) Stereotactic radiotherapy for pulmonary oligometastases: a systematic review. J Thorac Oncol 5:1091–1099PubMed
4.
Zurück zum Zitat Libshitz HI, Banner MP (1974) Spontaneous pneumothorax as a complication of radiation therapy to the thorax 1. Radiology 112:199–201CrossRefPubMed Libshitz HI, Banner MP (1974) Spontaneous pneumothorax as a complication of radiation therapy to the thorax 1. Radiology 112:199–201CrossRefPubMed
5.
Zurück zum Zitat Pezner RD, Horak DA, Sayegh HO et al (1990) Spontaneous pneumothorax in patients irradiated for Hodgkin’s disease and other malignant lymphomas. Int J Radiat Oncol Biol Phys 18:193–198CrossRefPubMed Pezner RD, Horak DA, Sayegh HO et al (1990) Spontaneous pneumothorax in patients irradiated for Hodgkin’s disease and other malignant lymphomas. Int J Radiat Oncol Biol Phys 18:193–198CrossRefPubMed
6.
Zurück zum Zitat Rowinsky EK, Abeloff MD, Wharam M (1985) Spontaneous pneumothorax following thoracic irradiation. Chest J 88:703–708CrossRef Rowinsky EK, Abeloff MD, Wharam M (1985) Spontaneous pneumothorax following thoracic irradiation. Chest J 88:703–708CrossRef
7.
Zurück zum Zitat Ohnishi K, Shioyama Y, Nomoto S et al (2009) Spontaneous pneumothorax after stereotactic radiotherapy for non-small-cell lung cancer. Jpn J Radiol 27:269–274CrossRefPubMed Ohnishi K, Shioyama Y, Nomoto S et al (2009) Spontaneous pneumothorax after stereotactic radiotherapy for non-small-cell lung cancer. Jpn J Radiol 27:269–274CrossRefPubMed
8.
Zurück zum Zitat Shioyama Y, Nakamura K, Anai S et al (2005) Stereotactic radiotherapy for lung and liver tumors using a body cast system: setup accuracy and preliminary clinical outcome. Radiat Med 23:407–413PubMed Shioyama Y, Nakamura K, Anai S et al (2005) Stereotactic radiotherapy for lung and liver tumors using a body cast system: setup accuracy and preliminary clinical outcome. Radiat Med 23:407–413PubMed
9.
Zurück zum Zitat Yoshitake T, Shioyama Y, Nakamura K et al (2009) A clinical evaluation of visual feedback-guided breath-hold reproducibility of tumor location. Phys Med Biol 54:7171–7182CrossRefPubMed Yoshitake T, Shioyama Y, Nakamura K et al (2009) A clinical evaluation of visual feedback-guided breath-hold reproducibility of tumor location. Phys Med Biol 54:7171–7182CrossRefPubMed
10.
Zurück zum Zitat Melton L 3rd, Hepper N, Offord K (1979) Incidence of spontaneous pneumothorax in Olmsted County, Minnesota: 1950 to 1974. Am Rev Respir Dis 120:1379–1382PubMed Melton L 3rd, Hepper N, Offord K (1979) Incidence of spontaneous pneumothorax in Olmsted County, Minnesota: 1950 to 1974. Am Rev Respir Dis 120:1379–1382PubMed
11.
Zurück zum Zitat Bense L, Eklund G, Wiman L-G (1987) Smoking and the increased risk of contracting spontaneous pneumothorax. Chest 92:1009–1012CrossRefPubMed Bense L, Eklund G, Wiman L-G (1987) Smoking and the increased risk of contracting spontaneous pneumothorax. Chest 92:1009–1012CrossRefPubMed
12.
Zurück zum Zitat Fiorelli A, Vicidomini G, Napolitano F et al (2011) Spontaneous pneumothorax after chemotherapy for sarcoma with lung metastases: case report and consideration of pathogenesis. J Thorac Dis 3:138–140PubMedCentralPubMed Fiorelli A, Vicidomini G, Napolitano F et al (2011) Spontaneous pneumothorax after chemotherapy for sarcoma with lung metastases: case report and consideration of pathogenesis. J Thorac Dis 3:138–140PubMedCentralPubMed
13.
Zurück zum Zitat Baydur A, Gottlieb LS (1976) Pneumopericardium and pneumothorax complicating bronchogenic carcinoma. West J Med 124:144–146PubMedCentralPubMed Baydur A, Gottlieb LS (1976) Pneumopericardium and pneumothorax complicating bronchogenic carcinoma. West J Med 124:144–146PubMedCentralPubMed
14.
Zurück zum Zitat Lai R-S, Perng R-P, Chang S-C (1992) Primary lung cancer complicated with pneumothorax. Jpn J Clin Oncol 22:194–197PubMed Lai R-S, Perng R-P, Chang S-C (1992) Primary lung cancer complicated with pneumothorax. Jpn J Clin Oncol 22:194–197PubMed
15.
Zurück zum Zitat Maniwa T, Nakagawa K, Isaka M et al (2011) Pneumothorax associated with treatment for pulmonary malignancy. Interact CardioVasc Thorac Surg 13:257–261CrossRefPubMed Maniwa T, Nakagawa K, Isaka M et al (2011) Pneumothorax associated with treatment for pulmonary malignancy. Interact CardioVasc Thorac Surg 13:257–261CrossRefPubMed
16.
Zurück zum Zitat Asai K, Shioyama Y, Nakamura K et al (2012) Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy: risk factors and dose–volume relationship. Int J Radiat Oncol Biol Phys 84:768–773CrossRefPubMed Asai K, Shioyama Y, Nakamura K et al (2012) Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy: risk factors and dose–volume relationship. Int J Radiat Oncol Biol Phys 84:768–773CrossRefPubMed
Metadaten
Titel
Clinical characteristics and outcome of pneumothorax after stereotactic body radiotherapy for lung tumors
verfasst von
Kaori Asai
Katsumasa Nakamura
Yoshiyuki Shioyama
Tomonari Sasaki
Yoshio Matsuo
Saiji Ohga
Tadamasa Yoshitake
Kotaro Terashima
Makoto Shinoto
Keiji Matsumoto
Hidenari Hirata
Hiroshi Honda
Publikationsdatum
01.12.2015
Verlag
Springer Japan
Erschienen in
International Journal of Clinical Oncology / Ausgabe 6/2015
Print ISSN: 1341-9625
Elektronische ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-015-0833-4

Weitere Artikel der Ausgabe 6/2015

International Journal of Clinical Oncology 6/2015 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.